Benzinga's Top Initiations
Analysts at Credit Suisse initiated coverage on shares of Ingredion (NYSE: INGR) with an “outperform” rating. The target price for Ingredion is set to $80. Ingredion's shares closed at $67.10 yesterday.
Canaccord Genuity initiated coverage on shares of Regeneron Pharmaceuticals (NASDAQ: REGN) with a “buy” rating. The target price for Regeneron Pharmaceuticals is set to $350. Regeneron Pharma's shares closed at $288.08 yesterday.
Morgan Stanley initiated coverage on shares of A10 Networks (NYSE: ATEN) with an “equal-weight” rating. A10 Networks' shares closed at $14.47 yesterday.
Analysts at Sterne Agee initiated coverage on shares of Actavis (NYSE: ACT) with a “buy” rating. The target price for Actavis is set to $230. Actavis' shares closed at $193.94 yesterday.
Latest Ratings for INGR
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.